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Peptide ligation and its application to protein engineering 
Graham J Cotton and Tom W Muir 
The ability to assemble a target protein from a series of peptide 
fragments, either synthetic or biosynthetic in origin, enables the 
covalent structure of a protein to be modified in an 
unprecedented fashion. The present technologies available for 
performing such peptide ligations are discussed, with an 
emphasis on how these methodologies have been utilized in 
protein engineering to investigate biological processes, 
Address: Laboratory of synthetic protein chemistry, The Rockefeller 
University, 1230 York Avenue, New York, NY 10021, USA. 
Correspondence: Tom W Muir 
Email: muirt@rockvax.rockefeller.edu 
Chemistry & Biology September 1999,6:R247-R256 
http:l/biomednet.com/elecref/10745521006R0247 
1074-5521/99/$ - see front matter 0 1999 Elsevier Science Ltd. 
All rights reserved. 
Introduction 
With the genetic blueprint of several organisms already 
available and the completion of the human genome 
project apparently well within sight, we are now facing a 
challenge worthy of a new millennium: characterization of 
many tens of thousands of novel gene products at the 
chemical and biological levels. Often referred to as the 
‘proteome project’, this is an enormously daunting under- 
taking, particularly given the emerging picture of com- 
plexity in biological processes. It seems likely that both 
established and novel technologies will have to be brought 
to bear on the problem, the latter probably requiring the 
input of researchers from many branches of science and 
engineering. Chemistry, and in particular organic chem- 
istry, is well poised to make a huge impact in this area, 
both through the use of small-molecule probes of biologi- 
cal processes [l] and, as will be the focus of this review, 
through the direct chemical manipulation of protein mole- 
cules. Precisely altering the covalent structure of a protein 
using synthetic chemistry provides a freedom in protein 
engineering unattainable by standard site-directed muta- 
genesis techniques. Accordingly, the development of 
approaches for the site-specific incorporation of unnatural 
amino acids into proteins has received considerable atten- 
tion in recent years, and several biosynthetic and synthetic 
strategies are now available for this purpose [Z-6]. 
This review will focus on just one of these technologies, 
namely the ‘peptide ligation’ approach [4,6]. Peptide lig- 
ation actually refers to a suite of approaches, all of which 
allow fully unprotected polypeptide building blocks to be 
regioselectively joined together in aqueous solution to 
create a target protein molecule. Ligation can be 
achieved either chemically [4], by incorporating unique 
functionalities at the amino and carboxyl termini of the 
peptide segments, or enzymatically using sophisticated 
reverse-proteolysis techniques [3,5]. The attraction of 
these modular ligation approaches is that they allow a 
selected region of a long protein sequence to be chemi- 
cally manipulated in a manner analogous to a synthetic 
peptide, enabling proteins to be site-specifically modi- 
fied in an hitherto unprecedented fashion. In this article, 
we will briefly review some recent technological develop- 
ments in the peptide-ligation field and then attempt to 
illustrate the extraordinary potential of this area in 
protein engineering through a series of examples. 
Bridging peptide chemistry and protein 
biotechnology 
There are several different chemical and enzymatic liga- 
tion approaches available for the assembly of proteins 
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from unprotected peptides (these have been reviewed 
extensively [3,4,6]). Indeed, small proteins and protein 
domains are now readily accessible to total synthesis, 
which is emerging as the method of choice for the rapid 
generation of these molecules [6]. Difficulties associated 
with the solid-phase peptide synthesis (SPPS) of peptides 
longer than -50 amino acids do, however, render the 
assembly of large protein targets (B 100 residues) a signifi- 
cant challenge using only two synthetic peptide segments. 
One solution to this problem has been to link together 
three or more synthetic peptides either using a combina- 
tion of orthogonal ligation approaches [7-91 or through the 
sequential use of the same methodology [9-121. Only a 
handful of proteins, however, have been prepared using 
these strategies to date, primarily because they are techni- 
cally demanding to perform. Perhaps as a consequence of 
this, recent developments in the field have centered on an 
alternative approach in which a combination of synthetic 
peptides and recombinantly derived polypeptides are 
used as the ligation building blocks. In principle, this 
semisynthetic strategy should allow synthetic access to 
extremely large protein systems by ligating short synthetic 
peptides (containing the chemical probe of interest) to 
much larger recombinant polypeptides. Pioneering work 
in this area includes the use of conformationally assisted 
condensation reactions [3], oxime and hydrazone bond 
forming ligation chemistries [13-151 and engineered 
peptide ligases [S]. 
The well-established ‘native chemical ligation’ method 
[16] has proved pivotal for many of the recent develop- 
ments in protein semisynthesis. As illustrated in 
Figure la, the first step in native chemical ligation 
involves the chemoselective reaction that occurs at physio- 
logical pH between a peptide fragment containing an 
amino-terminal cysteine residue and a second peptide 
fragment containing an athioester group. This initial 
transthioesterification reaction is then followed by a rapid 
intramolecular S+N acyl shift to generate an amide bond 
at the ligation junction. Note, additional cysteine residues 
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are permitted in one or both peptide segments because of 
the reversible nature of the initial transthioesterification 
step. This reaction has been widely used for ligating two 
synthetic peptide fragments together [6], where the nec- 
essa.ry reactive functionalities can be incorporated into the 
fragments during SPPS. Significantly, the necessary reac- 
tive groups can now be incorporated in a general fashion 
into recombinant proteins by utilizing new directives in 
protein engineering. 
Techniques for producing recombinant amino-terminal 
cysreine proteins, for use in native chemical ligations, have 
been established for some time [17]. It is only recently, 
however, that the requisite technologies have been devel- 
oped that enable recombinant ‘%hioester proteins to be 
generated. This breakthrough was achieved by manipulat- 
ing a naturally occurring biological phenomenon known as 
prorein splicing [18], a process that bears remarkable simi- 
larities to native chemical ligation (Figure 1). Protein splic- 
ing is a post-translational process in which a precursor 
protein undergoes a series of intramolecular rearrange- 
ments that result in precise removal of an internal region, 
referred to as an intein, and ligation of the two flanking 
sequences, termed exteins (Figure lb). Although there 
are, with one exception (see below), no sequence require- 
me:nts in either of the exteins, inteins are characterized by 
several conserved sequence motifs and approximately one 
hundred members of this protein domain family have 
now been identified (for a comprehensive listing, see 
www.neb.com/neb/Frame-tech.html). 
The first step in protein splicing involves an N+S (or 
N-30) acyl shift in which the N-extein unit is transferred 
to the sidechain SH or OH group of a conserved 
Cys/Ser/Thr residue, always located at the immediate 
amino terminus of the intein. Note, it has been speculated 
that the intein structure provides the driving force for this 
thermodynamically unfavorable rearrangement by twisting 
the scissile amide-bond into a higher energy conformation 
[19]. The entire N-extein unit is then transferred to a 
second conserved Cys/Ser/Thr residue at the intein- 
C-extein boundary (+ 1 position) in a transesterification 
step. The resulting branched intermediate is then resolved 
thrcough a cyclization reaction involving a conserved 
asparagine residue at the carboxyl terminus of the intein. 
The intein is therefore excised as a carboxy-terminal suc- 
cinimide derivative. In the final step, an amide bond is 
formed between the two exteins following an S+N (or 
0-+N) acyl shift, a step reminiscent of native chemical lig- 
ation. These mechanistic insights have led to the design of 
a number of mutant inteins that can only promote the first 
step of protein splicing [ZO-231. Proteins expressed as in- 
frame amino-terminal fusions to one of these engineered 
inteins can be cleaved by thiols via an intermolecular 
transthioesterification reaction to generate the recombi- 
nant protein ethioester derivative [Zl]. Peptide sequences 
containing an amino-terminal cysteine residue can then be 
specifically ligated to the carboxyl termini of these recom- 
binant ethioester proteins [24-261, in a procedure termed 
expressed protein ligation (EPL) or intein-mediated 
protein ligation (IPL). It is important to note inteins are 
not the only protein domains that can be used to generate 
recombinant protein athioesters. Indeed; Beachy and 
coworkers [27] have demonstrated that the autoprocessing 
domain of the protein Hedgehog (which is structurally 
related to inteins) can be used to generate semisynthetic 
proteins in a manner analogous to EPL. 
Methods for generating recombinant amino-terminal cys- 
teine proteins rely on cleavage of an appropriate precur- 
sor protein. In the enzymatic method developed by 
Verdine and coworkers [ 171, the recognition sequence for 
the protease factor Xa is introduced immediately in front 
of the cryptic amino-terminal cysteine in the protein. 
Because factor Xa cleaves directly after its recognition 
site, the desired amino-terminal cysteine protein is 
simply liberated by mild enzymatic treatment. Other pro- 
teases that cleave after their recognition site, such as 
enterokinase or ubiquitin carboxy-terminal hydrolase, 
should also be compatible with such an approach. An 
alternative strategy has recently been described that 
negates the need for this proteolytic step [Z&23,28]. This 
clever approach was again developed from studies on 
protein splicing, and utilizes inteins that have been engi- 
neered to promote direct cleavage at their carboxyl termi- 
nus, even with a cysteine residue at the + 1 position. The 
protein of interest is simply expressed as carboxy-termi- 
nal fusion to one of these engineered inteins and the 
desired material is liberated through spontaneous cleav- 
age at the intein-C-extein junction. 
Benzyl athioester containing peptides have been shown 
to be excellent substrates for the peptide ligase subtili- 
gase [‘29], a double mutant version of the serine protease 
subtilisin [29,30]. Welker and Scheraga [31] have recently 
shown that benzyl “thioester derivatives of recombinant 
proteins can be prepared using intein technology, a 
method that the authors suggest will allow synthetic pep- 
tides to be enzymatically ligated to the carboxyl terminus 
of recombinant proteins. Although this remains to be 
experimentally confirmed, this strategy would be a pow- 
erful complement to the earlier work of Wells and 
coworkers [3’2] who demonstrated that subtiligase can be 
used to ligate synthetic peptides to the amino terminus of 
recombinant proteins. 
The observation that protein splicing can be triggered by 
reconstituting inactive amino- and carboxy-terminal frag- 
ments of an intein [33-371 provides yet another applica- 
tion of this versatile process in protein engineering. 
Usually referred to as trans-splicing, this phenomenon 
allows two recombinant proteins to be joined together 
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in vitro. Each protein is expressed as a fusion with one of a 
pair of complementary intein fragments; simply combin- 
ing the two fusion proteins together under appropriate 
conditions results in a noncovalent association of the 
intein fragments, activation of protein splicing and so gen- 
eration of the desired recombinant protein chimera. Most 
trans-splicing studies have used artificially engineered 
split intein systems [33-3.51, although a naturally occurring 
split intein system has recently been observed [36] -a 
remarkable finding that adds an additional layer of com- 
plexity to the post-translational control of protein func- 
tion. Finally, a semisynthetic trans-splicing system has 
also been reported in which the carboxy-terminal compo- 
nent is a synthetic polypeptide, thereby providing another 
route to the preparation of semisynthetic proteins [37]. 
With the availability of the technologies outlined above, 
all possible permutations for joining recombinant and 
synthetic polypeptides together are, in principle, 
amenable through chemical/enzymatic ligation. As illus- 
trated in the following sections, this opens up many 
exciting opportunities for the application of synthetic 
chemistry to protein engineering. 
Protein-ligand interactions 
The ability to perform ‘unnatural amino acid mutagenesis’ 
makes the peptide ligation approach well suited for inves- 
tigating protein-ligand interactions. In a recent example, 
the interaction between the cr70 protein subunit of 
Es&tic&z coli RNA polymerase and the T4 anti-sigma 
protein (AsiA) was mapped using expressed protein liga- 
tion [ZS]. A truncated version of the 600 amino acid 070 
subunit lacking residues 567-600 was generated as the 
?hioester protein and found to lack AsiA binding activity. 
A synthetic peptide, corresponding to the missing 
residues, was then ligated to the carboxyl terminus of the 
truncated protein, which restored AsiA binding activity, 
thus elucidating the binding region. This functionally 
important carboxy-terminal region of 07~ can now be 
readily modified with all manner of biophysical probes 
and unnatural amino acids through ligation of the appro- 
priate synthetic peptide. 
An extension of native chemical ligation has been used to 
study the interaction between the AP-1 transcription acti- 
vator complex and its DNA recognition sequence [17,38]. 
An affinity cleavage reagent was prepared by chemically 
ligating a synthetic thioester derivative of EDTA to a 
series of recombinant AP-1 complexes (composed of c-Fos 
and c-Jun subunits) each possessing an amino-terminal 
cysteine residue generated by proteolytic cleavage [ 171. 
These semisynthetic proteins have been used in an 
elegant series of studies to elucidate the structural deter- 
minants of orientation within an NFAT*AP-l*DNA 
ternary complex [17], and to study how this orientation 
affects transcription activation [38]. 
An alternative ligation chemistry has been used to specifi- 
cally attach biophysical probes to recombinant proteins 
containing an amino-terminal serine residue, which can be 
converted into a glyoxyl group by mild periodate oxidation 
[13,39]. This aldehyde functionality can then be chemose- 
lectively reacted with compounds containing either 
hydrazide, aminooxy or thiosemicarbazide groups to 
produce the corresponding hydrazone, oxime or thiosemi- 
carbazole derivatives. This approach has been used to 
generate fluorescein and biotin derivatives of SH3 
domains for studying their ligand-binding properties 
[40,41]. In a seminal series of studies, Proudfoot and 
coworkers [42] have used these peptide ligation tech- 
niques to identify potent inhibitors of HIV-l infection 
based on the B-chemokine RANTES. A natural ligand for 
the HIV-l coreceptor CCR5, RANTES is a competitive 
inhibitor of HIV infection in vitro, but its pro-inflamma- 
tory properties render it of little value as an antiviral agent. 
Using an oxime ligation approach, these researchers were 
able to generate an amino-terminally modified version of 
the protein, AOP-RANTES, which blocks viral infection 
in a variety of immune cells, but importantly has no pro- 
inflammatory effects [42]. In a follow up series of studies, 
native chemical ligation has been used to prepare even 
more potent RANTES analogs and to facilitate high-reso- 
lution structural studies on these molecules [43,44]. 
The groups of Offord and Rose [13-151 have pioneered 
the use of the hydrazone- and oxime-forming reactions for 
chemically ligating synthetic and recombinant peptide 
fragments together. In one original application, ligation 
through hydrazone formation was used to investigate the 
biological activity of a series of granulocyte colony stimu- 
lating factor (G-CSF) analogs [13,14]. Recombinant frag- 
ments of the protein were first generated through specific 
proteolysis at in-built Lys-Ser sequences. Amino-terminal 
aldehyde groups or carboxy-terminal hydrazides were then 
incorporated into the appropriate fragments through perio- 
date oxidation or reverse proteolysis, respectively. Back- 
bone engineered derivatives of the 174-residue protein 
were therefore obtained by ligating the fragments back 
together, and importantly these were shown to retain full 
biological activity [13]. There followed a sophisticated 
extension of this work in which a central fragment of 
G-CSF was replaced by a synthetic peptide, essentially a 
kind of synthetic cassette mutagenesis [14]. The appropri- 
ate reactive functionalities were introduced into the syn- 
thetic peptide insert, which then allowed it to be 
regioselectively reacted with the flanking recombinant 
pieces of the protein (Figure Za). 
Site-specific modification of peptides and proteins with 
fluorescent probes offers an extremely powerful way of 
studying biological processes. In a recent example, a fluo- 
rescent analog of the Abelson (Abl) protein tyrosine kinase 
was generated in which a synthetic dansylated peptide 
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was inserted between the recombinantly derived Src 
ho!mology 3 (SH3) and SHZ domains of the protein [45]. 
To perform this synthetic cassette mutagenesis, a sequen- 
tial native chemical ligation strategy was developed in 
which all steps were performed at physiological pH 
(Figure Zb). In this method, the synthetic insert contained 
a carboxy-terminal thioester and a cryptic amino-terminal 
cysteine residue masked by a factor Xa cleavable pro- 
sequence. This reversible cysteine protection was neces- 
sary to prevent the insert reacting with itself in either an 
intermolecular or intramolecular fashion [11,46]. In the 
first reaction, recombinant amino-terminal cysteine 
Abl-SH2 (generated by factor Xa treatment of the appro- 
priate precursor) was ligated to the carboxyl terminus of 
the insert. The pro-sequence was then removed from the 
ligation product by treatment with factor Xa, to reveal the 
requisite amino-terminal cysteine for the second ligation 
reaction. This was facilitated by the addition of recombi- 
nant Abl-SH3 ‘%hioester (produced using intein technol- 
ogy) to yield the desired insertion product. A series of 
fluorescence studies indicated that this semisynthetic 
protein is a specific biosensor for high-affinity bidentate 
interactions involving the regulatory region of Abl [4.5]. 
T’his significant extension to EPL renders any region of a 
protein accessible to synthetic manipulation, at least in 
principle. Moreover, as the factor Xa cleavable pro- 
sequence can be incorporated at the DNA level, the insert 
in this strategy can itself be a recombinant protein. 
Indeed, recombinant sequences that contain both an 
amino-terminal cysteine and an “thioester have been used 
to produce circular and polymeric proteins [47,48], some- 
thing previously accomplished using synthetic peptides 
[11,46]. Two different approaches have been developed, 
both of which utilize inteins with amino-terminal cleavage 
activity to produce the athioester moiety, but differ in the 
way the amino-terminal cysteine is produced. In one 
report, the amino-terminal cysteine originates from factor 
Xa proteolysis [47], a strategy that allowed a circular 
version of an SH3 domain from the protein c-Crk to be 
efficiently generated and studied. In the so-called TWIN 
(TWO INtein) approach developed by Xu and coworkers 
[48], the requisite amino-terminal cysteine was generated 
using carboxy-terminal intein cleavage, a system that 
allowed a number of circular and polymeric peptides and 
proteins to be prepared. 
In an indication that peptide ligation could be a useful tool 
in cell biology, Tam and coworkers [49] used a thiazoli- 
dine ligation approach to attach a membrane-permeable 
peptide sequence (MPS) to a series of bioactive peptides. 
These researchers ligated a carboxy-terminal aldehyde 
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derivative of the MPS to an amino-terminal cysteine 
peptide and demonstrated that the resulting chimera was 
imported into eukaryotic cells [49]. The significance of 
this approach is that it should allow import of both peptide 
and nonpeptide bioactive molecules into cells. 
Structural studies 
Peptide ligation is beginning to make important contribu- 
tions to the field of structural biology, both by providing 
access to interesting molecules for high-resolution studies 
and, as will be the primary focus here, through the devel- 
opment of novel strategies that actually aid the structure 
determination process in nuclear magnetic resonance 
(NMR) spectroscopy and X-ray crystallography [32,50-521. 
Although developments over the last several years now 
allow proteins of up to -35 kDa to be studied using NMR 
spectroscopy, larger systems remain inaccessible because 
of the loss of spectral resolution that occurs as a result of 
increased line widths and increased numbers of signals 
with similar chemical shifts. The former of these problems 
has to some extent been addressed with the development 
of new methods for spectral observation (reviewed in 
[53]). Peptide ligation appears to offer a solution to the 
latter by allowing selected segments of a protein to be iso- 
topically labeled with NMR sensitive nuclei (Figure 3). In 
principle, segmental isotopic labeling of a large protein 
will lead to simplified NMR spectra; unlabeled regions of 
the protein can be filtered out using suitable heteronu- 
clear correlation experiments leaving only signals from the 
labeled part of the protein. Consequently, segmental 
labeling should allow NMR structure analysis of discrete 
regions of very large proteins (Figure 3). 
The feasibility of segmental isotopic labeling has recently 
been demonstrated using two different peptide ligation 
strategies--trans-splicing [SO] and expressed protein liga- 
tion [Sl]. Yamazaki and coworkers used a trans-splicing 
system based on the PI-&Z intein to selectively 15N label 
the carboxy-terminal domain of the E. coli RNA poly- 
merase a subunit [SO]. The carboxy-terminal domain of cx 
(aC) was expressed as two fragments, each attached to 
one half of the split intein system. Reassembly of the 
intein module induced protein splicing, resulting in the 
generation of the intact aC domain. Each half of the 
protein was selectively labeled by simply expressing the 
corresponding split intein fragment in 15N-enriched 
medium. Heteronuclear NMR experiments on these 
samples clearly revealed the improvement in spectral reso- 
lution that segmental labeling provides [SO]. In a comple- 
mentary study, expressed protein ligation was used to ‘5N 
label a single domain within a &c-homology domain pair 
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derived from the Abl protein tyrosine kinase [Sl]. An 
ethyl ‘%hioester derivative of recombinant Abl-SH3 was 
generated from the corresponding intein fusion and then 
chemically ligated, under physiological conditions, to 
%-labeled recombinant Abl-SH2 possessing a factor Xa 
generated amino-terminal cysteine. Comparison between 
the lH{15N} NMR spectra of fully labeled and segmental 
labeled Abl-SH(32) again illustrated the power of seg- 
mental isotopic labeling for studying large proteins using 
NMR spectroscopy. 
Peptide ligation also provides a route to protein derivatives 
for use in X-ray structure determination. In an early 
example, Wells and coworkers [32] used subtiligase-medi- 
ated peptide ligation to attach a mercurated-cysteine-con- 
taining peptide to human growth hormone. The ability to 
incorporate heavy-atom-laden sequences into proteins 
using ligation is likely to prove useful for solving the rela- 
tive phases in protein crystal structures using isomorphous 
replacement techniques. In a similar vein, peptide ligation 
also provides an alternative route to selenomethionine-con- 
taining proteins, which are now commonly used for solving 
the phase problem in conjunction with multiwavelength 
anomalous diffraction (MAD) [54]. The feasibility of this 
strategy was recently demonstrated by Lolis and coworkers 
[SZ] who used native chemical ligation to prepare a specific 
selenomethionine derivative of the chemokine MIP-II 
protein for subsequent crystallographic studies. 
Enzymology 
A number of enzyme-catalyzed reactions have been 
probed using peptide-ligation approaches. Fine details of 
enzyme mechanism can be directly studied through the 
incorporation of unnatural amino acids that have unique 
chemical properties into an enzyme active site. This 
approach is exemplified by a series of studies on the HIV- 
1 aspartyl-protease, a 99-residue polypeptide that is active 
as the homodimer. In a pioneering peptide-ligation study, 
the fully active protease was produced by chemical liga- 
tion of two unprotected synthetic fragments, each of -50 
amino acids in length [SS]. Synthetic access has allowed 
the covalent structure of the enzyme to be manipulated in 
ways possible only through chemical synthesis, by modify- 
ing the sidechains or backbone of the protein [56,57], or 
incorporating NMR probe nuclei in the active site [58], 
which has allowed fundamental mechanistic questions to 
be asked. Native chemical ligation has been used to study 
intermolecular interactions between various serine pro- 
teinases and the protein inhibitors OMKTYS [59] and 
eglin c [60]. Synthetic access to these protein inhibitors 
has allowed a systematic and quantitative analysis of the 
contribution of intermolecular backbone-backbone hydro- 
gen bonding to the stability of an enzyme-inhibitor 
complex. In the recent study on eglin c, a series of five 
protein analogs were prepared, each containing a unique 
mainchain -NHCO- to -COO- modification and designed 
to delete a particular hydrogen-bonding interaction with 
the proteinase [60]. Using these synthetic proteins, the 
authors were able to show that the contribution of hydro- 
gen-bonding to stability is highly context dependent and 
that there is a complex reciprocity between rigidity and 
adaptability in determining inhibition. 
In a beautiful piece of protein engineering, the 
124-residue enzyme ribonuclease A was assembled from 
six synthetic fragments using the subtiligase technology 
described earlier [30]. The catalytic histidine residues at 
positions 1’2 and 119 were then replaced by 4-fluorohisti- 
dine by modifying the corresponding synthetic peptide. 
The difference in pKa between this fluoro derivative and 
the natural histidine residue was used, among other 
things, to fully elucidate the general acid/general base 
mechanism employed by the enzyme. 
Intein technology is also beginning to see application in 
enzymology. In one recent example, the role of the 
carboxy-terminal carboxyl group of T7 RNA polymerase in 
catalysis was investigated [61]. The protein was expressed 
as an amino-terminal fusion to an intein and then cleaved 
with either cysteine, cysteine methyl ester or Z-mercapto- 
ethylamine to generate the corresponding carboxy-termi- 
nal cysteine, cysteine methyl ester or decarboxy-cysteine 
derivatives. Study of these semisynthetic analogs revealed 
a direct role for the carboxy-terminal carboxylate group in 
Mgz+-dependent catalytic activity. In a second example, 
Begley and coworkers [62] demonstrated that recombinant 
protein athiocarboxylates can be prepared from the corre- 
sponding intein fusions-a process that was developed to 
study the enzymology of thiamin biosynthesis, which 
involves a protein thiocarboxylate intermediate. 
Post-translational modifications 
The difficulty in producing proteins that have defined 
and specific patterns of post-translational modification 
has hindered studies on their functional role. This is an 
area in which peptide ligation could have a major impact, 
considering these alterations are central to the molecular 
events controlling cellular signaling networks and 
nature’s method for conferring functional diversity onto 
the same translated sequence. A typical example is the 
regulation of the Src family of protein tyrosine kinases 
through tyrosine phosphorylation of their carboxy-termi- 
nal tails. This post-translational event induces an 
intramolecular association between the tail region and an 
SHZ domain, which acts to down regulate kinase activity. 
This tyrosine phosphorylation reaction is catalyzed by the 
kinase Csk, which is highly homologous to Src family 
members but, interestingly, lacks this regulatory tail 
region. Peptide ligation was used to test the hypothesis 
that addition of a phosphotyrosine tail to Csk would result 
in down-regulation of its kinase activity, in a manner anal- 
ogous to Src kinases [24]. Full length Csk (450 amino 
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acids) and a short synthetic phosphopeptide were hooked 
together using EPL to give the -53 kDa phosphoprotein. 
The semisynthetic Csk protein did indeed form the 
expected intramolecular phosphotyrosine-SH2 associa- 
tion but surprisingly showed an increase in the catalytic 
activity relative to the wild-type protein. 
Systematic studies on glycoproteins have proved trouble- 
some because of difficulties in producing homogeneous 
samples of defined oligosaccharide structure. Conse- 
quently, a number of synthetic methods have been devel- 
oped to address this problem, including chemical and 
enzymatic ligation strategies (reviewed in [63]). The 
general approaches developed by Bertozzi and coworkers 
make use of the ability to incorporate unique ketone or 
aldehyde groups into peptides [64,65] and glycopeptides 
[66], respectively. Such groups can then be elaborated in a 
truly chemoselective fashion through oxime/hydrazone/ 
thiosemicarbazole chemistries to give the desired 
neoglycopeptides [64-66]. A related strategy has been 
developed in which free reducing sugars are chemoselec- 
tively reacted with peptides bearing aminooxy groups 
[67-691. Indeed, Mutter and coworkers [69] demonstrated 
that the use of N,O-disubstituted aminooxy groups 
allowed synthetic peptides to be glycosylated with high 
anomeric stereoselectivity. 
Chemical methods are now available for the preparation of 
phosphorylated, glycosylated and prenylated versions of 
small synthetic peptides. This, coupled with the availabil- 
ity of the peptide-ligation technologies discussed above, 
suggests that it should be possible to assemble large pro- 
teins that have defined post-translational modifications. 
Indeed, a chemoenzymatic ligation approach has recently 
been used to prepare unique glycoforms of the enzyme 
RNAse B from constituent peptide fragments [70]. It 
would therefore appear that synthetic chemistry is in an 
excellent position to drive fundamental advances in this 
important area of protein biology. 
Future outlook 
The peptide-ligation field has evolved rapidly over the last 
several years. This has brought us to the point where 
peptide building blocks can be efficiently ligated together 
using any one of a number of technologies. Moreover, as we 
have attempted to illustrate in this review, synthetic and 
recombinant polypeptides can now be freely intermixed in 
these ligation strategies, allowing extremely large semisyn- 
thetic proteins to be manipulated using the tools of organic 
chemistry. There are still several technical problems, 
however, that need to be addressed, particularly in the 
native chemical ligation strategy, which is arguably the most 
powerful peptide-ligation approach. One important chal- 
lenge for the future will be to develop ‘chemical tricks’ that 
negate the need for an amino-terminal cysteine residue in 
one of the peptide segments. Possible solutions to this 
problem might involve the use of transient auxiliary groups 
[71] or the use of conformationally-assisted ligations [72]. 
The field would also benefit greatly from the development 
of reliable routes to peptide athioesters using the 
Fmoc-SPPS strategy - the method of choice for synthesiz- 
ing phosphopeptides. Recent developments in resin-linker 
technology suggest this problem will be short lived [73-751. 
The ability to perform sequential ligation reactions is 
extremely exciting because it provides synthetic access to 
very large proteins and, when interfaced with expressed 
protein ligation, allows the segmental isotopic labeling of 
internal regions of a protein. As pointed out earlier, these 
sequential ligation strategies are technically demanding to 
perform, and therefore the routine application of this 
approach will require new developments. Perhaps the 
most likely solution to this problem will involve perform- 
ing stepwise ligations on a solid support (akin to SPPS), 
something that has already been formally achieved using 
synthetic peptides [10,11,76] and, in our own group, using 
a combination of synthetic and recombinant peptides 
(G.J.C. and T.W.M. unpublished observations). 
This review began by pointing out the enormous opportu- 
nities that the proteome project presents to chemists. The 
field of peptide ligation is sure to play an expanding role 
in this endeavor by providing rapid access to novel 
sequences through total synthesis and by facilitating new 
lines of investigation in the areas ranging from structural 
biology and biochemistry to basic cell biology. 
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